Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible ...

Ellen’s experience highlights the growing promise of blood-based testing for Alzheimer’s. By identifying disease-specific biomarkers in the bloodstream, these tests offer a minimally invasive ...

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...

The interaction between the brain and the vascular system could hold the key to lowering disease risk. According to the ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

Alzheimer’s blood tests are the key to widespread prevention of dementia, experts say. If people can be diagnosed in their doctor’s office, they can more immediately move into preventive care ...